Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-01 O'Byrne Jason CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +650,000 650,000
2026-07-24 Harmon Cyrus Director Sale −12,500 $11.71 $146K 702,770
2026-07-23 Harmon Cyrus Director Sale −12,500 $11.58 $145K 715,270
2026-06-18 Raman Prakash Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 Harmon Cyrus Director Grant or award · Stock Option (Right to Buy) +29,500 29,500
2026-06-18 Hrustanovic Gorjan Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 Larson Yi Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 Graham G. Walmsley Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 Horning Sandra Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 Garland J. Scott Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 CLARK IAN T Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 RAPPAPORT ANDREW Director Grant or award · Stock Option (right to buy) +29,500 29,500
2026-06-18 BVF PARTNERS L P/IL Director Grant or award · Stock Option (Right to buy) +29,500 29,500
2026-04-28 Raman Prakash Director Grant or award · Stock Option (Right to Buy) +2,911 2,911
2026-04-28 Raman Prakash Director Grant or award · Stock Option (Right to Buy) +24,150 24,150
2026-03-04 Mitchell Shawnte CHIEF LEGAL OFFICER Exercise or conversion +25,000 $4.37 $109K 25,000
2026-03-04 Mitchell Shawnte CHIEF LEGAL OFFICER Sale −24,767 $24.25 $601K 233
2026-03-04 Mitchell Shawnte CHIEF LEGAL OFFICER Sale −233 $24.69 $6K 0
2026-03-04 Mitchell Shawnte CHIEF LEGAL OFFICER Exercise or conversion · Stock Option (Right to Buy) −25,000 410,000

Page 1 of 24 · 465 trades